Intranasal delivery for peptide and siRNA to the brain using lipid-based nanocarriers for the treatment of neuroinflammation
Neurodegenerative diseases are the most prevalent brain diseases affecting more than 5.5 million people worldwide. If left unconstrained, 30 years from now, more than 12 million Americans will suffer from these diseases. neuro-inflammation has been one of the common denominator in broad spectrum of...
| Published: |
|
|---|---|
| Online Access: | http://hdl.handle.net/2047/D20198907 |